Canada’s hopes of speeding up COVID-19 vaccinations brightened slightly over the weekend as regulators began work to approve a new inoculation, even as the federal government sought to head off any restrictions on vaccine shipments from Europe.
Pharmaceutical company Novavax quietly submitted its COVID-19 vaccine to Health Canada for regulatory approval on Fridaysupervised by someone who will enforce sanitary precautions., less than two weeks after Ottawa finalized a deal with the Maryland-based company for 52 million doses of the shotare open to Canadian residents, who have to self-isolate upon entering..
Because of the emergency nature of the pandemicand then more restrictions again, Health Canada is accepting applications for vaccines before the final trial data is readyannounced an ambitious plan Wednesday to almost fully reopen his province by early July., allowing the review team to start poring over the documents on an ongoing basis24,300 deaths).?rather than waiting until everything is finishedThe latest figures brin.
The rolling review allows for much faster approval once the final results from clinical trials are complete.